|
Phase 1
|
NCT07453836 |
Mar 2026 → Mar 2027 expected |
autoimmune hemolytic anemia |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Not yet recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07236762 |
Nov 2025 → Nov 2026 expected |
Sjogren syndrome, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, lupus nephritis +2 |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07104721 |
Aug 2025 → Aug 2026 overdue |
anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, lupus nephritis, myositis disease +2 |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06978647 |
May 2025 → May 2026 overdue |
Sjogren syndrome, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, idiopathic inflammatory myopathy +4 |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT06943937 |
Apr 2025 → Apr 2026 overdue |
autoimmune thrombocytopenia, lupus nephritis |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT07075484 |
Jan → Dec 2025 |
autoimmune hemolytic anemia |
China Immunotech (Beijing) Biotechnology Co., Ltd. |
Completed
|
No outcome recorded
|